Personal information

Cancer Metastasis Chemoprevention; Nitric Oxide; S-nitrosocaptopril
China, United States

Biography

Dr. Lee Jia is Distinguished Professor and the Director of Marine Drug R&D Center, Minjiang University, China. His research focuses on three aspects: 1) Cancer pre-metastasis chemoprevention; 2) Nitric oxide and S-nitrosylation bioengineering; 3) Nanotechnology for innovative drug delivery, biosensors, and biomaterials for precisely targeting CTCs. He received many prestigious awards, including the 2004 National Cancer Institute Merit Award (NIH); the 2012 American Association of Pharmaceutical Scientists (AAPS) Leadership Award; Fujian Science & Technology Innovation Leadership Award (2011); “The China Recruitment Program of Global Experts” (2011); “The Most Cited Chinese Researchers” selected by Scopus/Elsevier in the field of Pharmacology & Pharmaceuticals (2014-2019), or Chemical Engineering & Technology (2020); “Honorable Fuzhou City Citizen” (2014) awarded by the Fuzhou City Standing Committee. China Industry-University-Research Institute Cooperation Innovation (individual) Award (2017); WuXi AppTec Life Chemistry Research Award (2020); He was elected as the Fellow of AAPS (2011), and Academician of International Eurasian Academy of Sciences (IEAS; 2020); He was Chair of Section of Drug Discovery & Development (DDD) of AAPS (2019-2012), and Founding Chair of Section of Intelligent Functional Pharmaceutics, Chinese Pharmaceutical Association (CPA; 2021-). He has contributed >220 peer-reviewed papers, some published in the most impactful journals such as Nature, Science, Nature Communications, PNAS, Nano Today, Adv. Funct. Mater., Blood, Chem. Mater., Biomaterials. His work has been cited 16000 times, with an H-index 61, i10-index 190 (google scholar).
Dr. Jia obtained his PhD in Pharmacology in 1994 under supervision of Dr. Robert Furchgott (the 1998 Nobel Laureate) of the State University of New York, USA.

Activities

Employment (3)

Marine Drug R&D Center, College of Materials and Chemical Engineering, Minjiang University: Fuzhou, CN

2019-01 to present | Director
Employment
Source: Self-asserted source
Li Jia 贾力

Cancer Metastasis Prevention & Alert Center, Fuzhou University, China: Fuzhou, Fujian, CN

2012 to present | Director
Employment
Source: Self-asserted source
Li Jia 贾力

Division of Cancer Treatment & Diagnosis, National Cancer Institute/ NIH: Rockville, US

2002-04 to 2012-04 | Project Manager (Developmental Therapeutics Program (DTP))
Employment
Source: Self-asserted source
Li Jia 贾力

Education and qualifications (2)

Duke University School of Medicine: Durham, NC, US

Education
Source: Self-asserted source
Li Jia 贾力

State University of New York, NY, USA: New York, NY, US

1990 to 1994 | PhD
Education
Source: Self-asserted source
Li Jia 贾力

Professional activities (3)

Chinese Chemical Society: Beijing, CN

2021-10 to present | Fellow, and Senior Member
Membership
Source: Self-asserted source
Li Jia 贾力

Chinese Pharmacological Society: Fujian, CN

2012 to present | Senior Member
Membership
Source: Self-asserted source
Li Jia 贾力

American Association of Pharmaceutical Scientists (AAPS): VE, US

1999 to present | Fellow
Membership
Source: Self-asserted source
Li Jia 贾力

Peer review (14 reviews for 5 publications/grants)

Review activity for ACS applied materials & interfaces. (6)
Review activity for ACS biomaterials science & engineering. (1)
Review activity for ACS nano. (2)
Review activity for Analytical chemistry. (4)
Review activity for Journal of agricultural and food chemistry. (1)